Neurology

Head-to-head comparison of migraine meds reveals top options

May 3, 2023

Oral antiamyloid shows disease-modifying potential Phase 3 trial underway

May 3, 2023

Neurology

FDA expands atogepant approval to include chronic migraine

May 2, 2023

Donanemab bests aducanumab in head-to-head Alzheimer’s trial

May 1, 2023

New hope for adult children with ‘failure to launch’ syndrome

May 1, 2023

Cautious optimism for new Alzheimer’s disease biomarkers and treatments, expert says

May 1, 2023

Unawareness of memory slips could indicate risk for Alzheimer’s

April 27, 2023

Noninvasive testing in midlife flags late-onset epilepsy risk

April 27, 2023

Neurology

FDA gives fast-track approval to new ALS drug

April 27, 2023

Atogepant prevents episodic migraine in some difficult-to-treat cases

April 26, 2023

Neurology

Walnuts linked to improved attention, psychological maturity in teens

April 26, 2023

Predicting BPD vs. bipolar treatment response: New imaging data

April 25, 2023

Neurology

Early menopause, delayed HT tied to Alzheimer’s pathology

April 21, 2023

Obstructive sleep apnea linked to early cognitive decline

April 19, 2023

Urban green and blue spaces linked to less psychological distress

April 12, 2023